In the BioHarmony Drug Report Database
Clofibrate
Atromid-s (clofibrate) is a small molecule pharmaceutical. Clofibrate was first approved as Atromid-s on 1982-01-01. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. The pharmaceutical is active against peroxisome proliferator-activated receptor alpha.
Trade Name
|
Atromid-s |
|---|---|
Common Name
|
clofibrate |
ChEMBL ID
|
CHEMBL565 |
Indication
|
coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia |
Drug Class
|
Antihyperlipidemics (clofibrate type) |
Image (chem structure or protein)